Log In
BCIQ
Print this Print this
 

Pulmicort, budesonide turbuhaler

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionDry powder corticosteroid for inhalation
Molecular Target Corticoid receptors
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
PartnerVectura Group plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$634.2M

$100.6M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/10/2016

$634.2M

$100.6M

0

Get a free BioCentury trial today